Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate

Affiliations

¹ Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, MD, USA.
² Department of Pathology and Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA.
³ Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, MD, USA. Electronic address: adam.sowalsky@nih.gov.

Comment

Scott Wilkinson et al. Eur Urol. 2021 Sep.

. 2021 Sep;80(3):e83-e84.

doi: 10.1016/j.eururo.2021.06.002. Epub 2021 Jun 18.

¹ Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, MD, USA.
² Department of Pathology and Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA.
³ Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, MD, USA. Electronic address: adam.sowalsky@nih.gov.

No abstract available

Comment on

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Wilkinson S, Ye H, Karzai F, Harmon SA, Terrigino NT, VanderWeele DJ, Bright JR, Atway R, Trostel SY, Carrabba NV, Whitlock NC, Walker SM, Lis RT, Abdul Sater H, Capaldo BJ, Madan RA, Gulley JL, Chun G, Merino MJ, Pinto PA, Salles DC, Kaur HB, Lotan TL, Venzon DJ, Choyke PL, Turkbey B, Dahut WL, Sowalsky AG. Wilkinson S, et al. Eur Urol. 2021 Dec;80(6):746-757. doi: 10.1016/j.eururo.2021.03.009. Epub 2021 Mar 27. Eur Urol. 2021. PMID: 33785256 Free PMC article.
Re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate.
Cimadamore A, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R. Cimadamore A, et al. Eur Urol. 2021 Sep;80(3):e81-e82. doi: 10.1016/j.eururo.2021.06.001. Epub 2021 Jun 18. Eur Urol. 2021. PMID: 34148712 No abstract available.